A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This aim of study is to evaluate the safety and efficacy of olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy by a randomized, double-blind, placebo-controlled trial.
Epistemonikos ID: 52812884c20c1701a7bd3eec7d4058d61d2cd400
First added on: May 12, 2024